ZVRA Earnings

Quarterly EPS
$-0.69
Q3 2024
$-0.67
Q4 2024
$-0.06
Q1 2025
$1.24
Q2 2025
$-0.01
Q3 2025
$0.22
Q4 2025
$0.62
Q1 2026
$0.14
Q2 2026
Latest Revenue39.7M
Latest Net Income8.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.1439.7M8.8M+53.3%-88.7%
Q1 2026$0.6236.2M37.9M+77.5%+1,133.3%
Q4 2025$0.2234.1M12.2M+183.4%+132.8%
Q3 2025-$0.0126.1M-544000+605.4%+98.6%
Q2 2025$1.2425.9M74.7M+481.7%+358.3%
Q1 2025-$0.0620.4M-3099000+495.6%+85.0%
Q4 2024-$0.6712.0M-35739000-6.8%-31.4%
Q3 2024-$0.693.7M-33225000+27.6%-130.0%
Q2 2024-$0.484.4M-19925000
Q1 2024-$0.403.4M-16622000
Q4 2023-$0.5112.9M-19892000
Q3 2023-$0.302.9M-10367000
Zevra Therapeutics (ZVRA) — Earnings